|Grant Affiliation:||Ho: Enhancing Innate Immune Activation|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2003-12-18|
|Study Made Public:||2011-02-25|
Screen for broadly neutralizing sera among the Aaron Diamond AIDS Research Center HIV+ Patient Cohort in New York City [Original Study Title: HIV Controllers]
CAVD 287 is an immunogenicity study to evaluate and characterize the neutralization activity of broadly neutralizing antibodies in HIV controllers.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.